alexa
Reach Us +1 218 451 2974
Rachel F Tyndale | OMICS International
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Recommended Conferences
Relevant Topics

Rachel F Tyndale

Rachel F Tyndale Rachel F Tyndale
Scientist and Head of Pharmacogenetics in CAMH's Neuroscience Department.
Professor in the Departments of Pharmacology, Toxicology and Psychiatry and also the Endowed Chair in Addictions at the University of Toronto.
Research Interest

Dr. Tyndale is investigating genetic risk factors for drug dependence to better understand the mechanisms involved with drug abuse and to optimize treatment approaches. Drugs under study include ethanol, opiates, benzodiazepines and amphetamines with a focus on nicotine and smoking. She is tackling the serious public health issue of smoking and trying to find answers to the questions why some people smoke more than others, and why some find it easier to quit. Dr. Tyndale’s goal is to use genetic information to personalize treatment for people who want to quit smoking. The techniques range from molecular identification and characterization of novel genetic polymorphisms to in vivo pharmacokinetic, abuse liability, epidemiological, and treatment studies. Another area of her research involves the study of the unique regulation, function, and toxicity of cytochrome P450 enzymes in the central nervous system. Dr. Tyndale is assessing how commonly used drugs such as nicotine or ethanol regulate these enzymes and the subsequent impact on treatment drugs, as well as drugs of abuse. The techniques range from western blotting and mRNA approaches, to in vitro and in vivo drug metabolism, to behavioural/toxicity studies.

Publications

Global Speakers in the subject

Global Experts in the subject

Relevant Conferences
Top